欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PL/H/0791/001
药品名称Solifenacin succinate + Tamsulosin hydrochloride Adamed
活性成分
    • solifenacin succinate 6.0 mg
    • tamsulosin hydrochloride 0.4 mg
剂型Modified-release tablet
上市许可持有人Adamed Pharma S.A. ul. Mariana Adamkiewicza 6a 05-152 Czosnow
参考成员国 - 产品名称Poland (PL)
Solifenacin succinate + Tamsulosin hydrochloride Adamed
互认成员国 - 产品名称
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Bulgaria (BG)
    • Romania (RO)
      Solifenacin +Tamsulosin Adamed 6 mg/0,4 mg comprimate cu eliberare modificată
    • Croatia (HR)
许可日期2022/06/23
最近更新日期2024/08/01
药物ATC编码
    • G04CA53 tamsulosin and solifenacin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase